Distribution Partnerships Strategic opportunity to expand portfolio via new distributors such as AtlasXomics and potential future partners in epigenetics, diagnostics, and research products to Australia and New Zealand.

Epigenetics Expansion Recent collaboration with AGRF to offer epigenetic services using CUT&RUN and CUT&Tag technologies signals demand for specialized epigenetics capabilities and related reagents, enabling cross-sell of assay kits, antibodies, and supportive instrumentation.

Clinical and Point-of-C care Synergy Strong orientation toward Clinical Diagnostics, Molecular Diagnostics and Point of Care presents cross-selling opportunities with labs and clinics seeking integrated workflows and supplier of multiple diagnostics modalities.

Tech Stack Leverage Utilize Salesforce and cloud-based tools to nurture partner and customer relationships, automate workflows, and targeted outreach in Australia and New Zealand, accelerating deal cycles with existing tech investments.

Growth Potential Revenue in the lower mid-market range with 11-50 employees indicates room to scale with mid-size lab customers, distributors, and regional research institutes as preferred suppliers for diagnostics and research products.